Global Coalition on Aging Leads Conversation on Elder Care Innovation and Economic Growth at APEC High-Level Meeting on Health & the Economy

Global experts highlight innovations for healthy aging across the APEC region

Puerto Varas, CHILE (August 21, 2019) – The Global Coalition on Aging (GCOA) today joined global experts and government leaders for the 9th APEC High-Level Meeting on Health & the Economy. At the meeting, GCOA CEO Michael Hodin led a panel discussion highlighting best practices in healthy aging and elder care from around the region, stressing the importance of investing in prevention and healthy aging for economies to achieve long-term fiscal sustainability.

“APEC economies are leading the way in recognizing population aging as a driver of innovation,” said Hodin during the panel discussion. “And we are finally beginning to view these innovations – from adult vaccines to artificial intelligence and elder homecare to address conditions of aging such as fragility fractures and heart failure – as investments in our future economic growth and the sustainability of our public systems, each of which illustrates the importance that prevention strategies have in assisting all societies to meet the goals of healthier and more active aging for all.”

APEC economies are among those with the most rapidly aging populations in the world. Noting the importance of adapting not only health care systems, but entire economies to the needs of an aging population, speakers identified new and innovative strategies and partnerships that APEC economies can use to embrace and support the needs of their aging populations. In doing so, APEC economies can foster economic growth for all citizens, even as their aging population increases.

“A central goal of APEC economies must be to keep our populations healthy, active, and engaged, which requires investments in functional ability,” said PAHO’s Dr. Enrique Vega Garcia. “Studies show that increased mobility promotes a higher quality of life and greater social and economic participation, all of which contribute to greater health and wellbeing, and lower costs. For instance, by focusing on preventive strategies that address the conditions of aging, such as fragility fractures, vision loss, and vulnerability to vaccine-preventable diseases, we can help improve mobility and independence for aging populations across APEC economies.”

As an example of progress in healthy aging, this year’s APEC HLM has shined a light on the importance of adult vaccines, with the power to prevent diseases including pneumococcal pneumonia and influenza, as a central element of 21st-century public health strategies to match the achievements in childhood immunization from last century.

The two-day event convened representatives from 21 APEC economics, along with representatives from academia, private sector companies and NGOs.

“Strategic investments to keep our populations healthy and active create a virtuous cycle of innovation, growth, and widespread benefit,” said Penny Wan, Regional VP and General Manager, JAPAC at Amgen. “At Amgen, we recognize that aging trends demand action and advocacy towards prediction and prevention of fragility fractures, heart failure, and other conditions that increase with age. We should be investing in solutions that make this possible, which we know will pay critical dividends, not just for individuals who achieve healthier and more active aging, but for their families and society as a whole.”

The panel on elder care innovation and economic growth was moderated by Hodin and included distinguished speakers Sebastian Villarreal,Undersecretary of Social Services at the Ministry of Social Development and Family in Chile; Dr. Jane Barratt, Secretary General of the International Federation on Ageing; Dr. Enrique Vega Garcia, Unit Chief of Healthy Life Course at PAHO/WHO; Paul Neureiter, Executive Director for International Government Affairs, Amgen; and Professor Ian Wronski AO, Deputy Vice Chancellor of the Division of Tropical Health and Medicine at James University.

 

 

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.